Rhodium-Catalyzed Asymmetric C–H Functionalization Reactions
Chemical Reviews · 23.08.2023 · 123 (16) · 10079-10134
DOI: 10.1021/acs.chemrev.3c00149 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Reviews, online erschienen am 01.08.2023. Verfasst von Chen-Xu Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory, State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese …. Die Arbeit wurde bisher 268-mal zitiert (Crossref) und nennt 279 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Tencent, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- New Cornerstone Science Laboratory, State Key Laboratory of Organometallic Chemistry, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Chinese Academy of Sciences, 345 Lingling Lu, Sha…
ORCID-Profile: Qing Gu, Shu-Li You
Förderung
- National Key Research and Development Program of China
- Tencent
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- New Cornerstone Science Foundation
Zitieren
APA
Liu, C. X., Yin, S. Y., Zhao, F., Yang, H., Feng, Z., Gu, Q., & You, S. L. (2023). Rhodium-Catalyzed Asymmetric C–H Functionalization Reactions. Chemical Reviews, 123(16), 10079-10134. https://doi.org/10.1021/acs.chemrev.3c00149
Vancouver
Liu CX, Yin SY, Zhao F, Yang H, Feng Z, Gu Q, et al. Rhodium-Catalyzed Asymmetric C–H Functionalization Reactions. Chemical Reviews. 2023;123(16):10079-10134. doi:10.1021/acs.chemrev.3c00149
BibTeX
@article{Liu2023,
author = {Liu, Chen-Xu and Yin, Si-Yong and Zhao, Fangnuo and Yang, Hui and Feng, Zuolijun and Gu, Qing and You, Shu-Li},
title = {Rhodium-Catalyzed Asymmetric C–H Functionalization Reactions},
journal = {Chemical Reviews},
year = {2023},
volume = {123},
number = {16},
pages = {10079--10134},
doi = {10.1021/acs.chemrev.3c00149}
}
EUVIMED